Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam I Riker

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
Ochsner Journal|June 27, 2022
Hospital-Based Same-Day Compared to Overnight-Stay Mastectomy: An American College of Surgeons National Surgical Quality Improvement Program AnalysisUdai S Sibia, John R Klune, Justin J Turcotte, et al.
Genes & Diseases|May 17, 2021
Cyclin G2, a novel target of sulindac to inhibit cell cycle progression in colorectal cancerHongyou Zhao, Bin Yi, Zhipin Liang, et al.
Oncology|March 11, 2010
Elevated osteopontin levels in metastatic melanoma correlate with epigenetic silencing of breast cancer metastasis suppressor 1Brandon J Metge, Suhu Liu, Adam I Riker, et al.
Cancer Control : Journal of the Moffitt Cancer Center|July 4, 2008
The impact of genomics in understanding human melanoma progression and metastasisSuping Ren, Suhu Liu, Paul Howell, et al.
The Journal of Experimental Medicine|June 5, 2002
Identification of a mutated fibronectin as a tumor antigen recognized by CD4+ T cells: its role in extracellular matrix formation and tumor metastasisHelen Y Wang, Juhua Zhou, Kuichun Zhu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 27, 2006
Immunostimulatory effects of CpG-ODN upon dendritic cell-based immunotherapy in a murine melanoma modelShari Pilon-Thomas, Wenbin Li, Jon J Briggs, et al.
Frontiers in Bioscience (Landmark Edition)|January 4, 2011
Emerging metabolic targets in cancer therapyYuhua Zhao, Hao Liu, Adam I Riker, et al.
Ochsner Journal|October 3, 2022
Improving Operating Room Efficiency: Relocating a Surgical Oncology Program Within a Health Care SystemJames W Orr, Ann M Thompson, Dennis Bruens, et al.
Cancer Control : Journal of the Moffitt Cancer Center|July 4, 2008
Activated stat-3 in melanomaJane L Messina, Hua Yu, Adam I Riker, et al.
Ochsner Journal|June 24, 2024
Male Breast Cancer With Dual BRCA2 and BRIP1 Deleterious Gene MutationsShivani B Badve, Emily Kim, Udai S Sibia, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Ochsner Journal|June 27, 2022
Hospital-Based Same-Day Compared to Overnight-Stay Mastectomy: An American College of Surgeons National Surgical Quality Improvement Program AnalysisUdai S Sibia, John R Klune, Justin J Turcotte, et al.
Genes & Diseases|May 17, 2021
Cyclin G2, a novel target of sulindac to inhibit cell cycle progression in colorectal cancerHongyou Zhao, Bin Yi, Zhipin Liang, et al.
Oncology|March 11, 2010
Elevated osteopontin levels in metastatic melanoma correlate with epigenetic silencing of breast cancer metastasis suppressor 1Brandon J Metge, Suhu Liu, Adam I Riker, et al.
Cancer Control : Journal of the Moffitt Cancer Center|July 4, 2008
The impact of genomics in understanding human melanoma progression and metastasisSuping Ren, Suhu Liu, Paul Howell, et al.
The Journal of Experimental Medicine|June 5, 2002
Identification of a mutated fibronectin as a tumor antigen recognized by CD4+ T cells: its role in extracellular matrix formation and tumor metastasisHelen Y Wang, Juhua Zhou, Kuichun Zhu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 27, 2006
Immunostimulatory effects of CpG-ODN upon dendritic cell-based immunotherapy in a murine melanoma modelShari Pilon-Thomas, Wenbin Li, Jon J Briggs, et al.
Frontiers in Bioscience (Landmark Edition)|January 4, 2011
Emerging metabolic targets in cancer therapyYuhua Zhao, Hao Liu, Adam I Riker, et al.
Ochsner Journal|October 3, 2022
Improving Operating Room Efficiency: Relocating a Surgical Oncology Program Within a Health Care SystemJames W Orr, Ann M Thompson, Dennis Bruens, et al.
Cancer Control : Journal of the Moffitt Cancer Center|July 4, 2008
Activated stat-3 in melanomaJane L Messina, Hua Yu, Adam I Riker, et al.
Ochsner Journal|June 24, 2024
Male Breast Cancer With Dual BRCA2 and BRIP1 Deleterious Gene MutationsShivani B Badve, Emily Kim, Udai S Sibia, et al.
Pageof 9